Author: Deepak Kumar; Nitin Sharma; Murali Aarthy; Sanjeev Singh; Rajanish Giri
Title: Mechanistic insights into Zika virus NS3 helicase inhibition by Epigallocatechin-3-gallate: Supplementary Files Document date: 2019_1_26
ID: k11iupe0_5
Snippet: Like other flavivirus helicases, ZIKV helicase also belongs to SF2 (Superfamily) family and a phylogenetically close relative of Murray Valley encephalitis virus (MVEV), DENV4, and DENV2 (18) . Full-length NS3 protein has N-terminal protease activity, and C-terminal is associated with helicase activity. ZIKV NS3 helicase (172-617 residues) is a large protein containing three domains where domain 1 (residues175-332) and domain 2 (residues 333-481).....
Document: Like other flavivirus helicases, ZIKV helicase also belongs to SF2 (Superfamily) family and a phylogenetically close relative of Murray Valley encephalitis virus (MVEV), DENV4, and DENV2 (18) . Full-length NS3 protein has N-terminal protease activity, and C-terminal is associated with helicase activity. ZIKV NS3 helicase (172-617 residues) is a large protein containing three domains where domain 1 (residues175-332) and domain 2 (residues 333-481) forms NTPase pocket and domain 3 (residues 481-617) in association with domain 1 and 2 forms RNA binding tunnel (21) . Though ZIKV helicase is well structured, active sites at NTPase and RNA binding pockets contain highly flexible or disordered P-loop (193-203 residues) and RNA binding loop (244-255 residues) respectively, which are critical for their specific function (21, 22) . In general, past decade has evidenced the significance contribution of intrinsically disordered proteins/regions (IDRs/IDPs) in almost all biological processes and the regions are considered as novel therapeutic targets (23) (24) (25) (26) (27) (28) (29) . Despite the conversed active site amino acid residues among flavivirus helicases, ZIKV helicase show different motor domain movements and RNA binding modes when compared to DENV helicase (21) . These vital functions of ZIKV helicase encourage to screen for antiviral molecules against its active sites. In a recent study, we have determine the inhibitory potential of a small molecule (HCQ) against ZIKV protease with computational and enzyme kinetics studies (30) . Therefore, in this article, we have used molecular docking and simulation approach to find out a significant binding cavity for EGCG. Further, we have verified our computational findings by in vitro enzyme assay to probe the significant binding of EGCG at NTPase site of ZIKV helicase.
Search related documents:
Co phrase search for related documents- amino acid and bind loop: 1, 2, 3
- amino acid and bind mode: 1, 2, 3
- amino acid and bind pocket: 1, 2
- amino acid and biological process: 1, 2, 3, 4
- amino acid and computational finding: 1
- amino acid and domain contain: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
- amino acid and encephalitis virus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29
- amino acid and enzyme computational: 1
- amino acid and flavivirus helicase: 1
- amino acid and helicase activity: 1, 2, 3, 4, 5, 6, 7, 8, 9
- amino acid and inhibitory potential: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
- amino acid and large protein: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51
- amino acid and novel therapeutic target: 1, 2, 3
- amino acid and NTPase site: 1, 2
- amino acid and past decade: 1, 2, 3, 4, 5, 6, 7, 8, 9
- amino acid and protease activity: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29
- amino acid and protein region: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75
- amino acid and recent study: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- amino acid and significant binding: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28
Co phrase search for related documents, hyperlinks ordered by date